Related Experiment Video

Updated: Jan 8, 2026

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts
10:27

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Published on: July 25, 2020

7.8K

Genomic alterations linked to recurrence risk in high-grade serous ovarian cancer revealed by deep targeted

Young-Hoon Park1, Seong-Woo Park2, Jee-Whan Kim3

  • 1Department of Obstetrics and Gynecology, Gangnam Severance Hospital, Yonsei University College of Medicine, 211 Eonju-Ro, Gangnam-Gu, Seoul, 06273, Korea.

Scientific Reports
|December 18, 2025
PubMed
Abstract

No abstract available in PubMed .

Keywords:
NF1ROS1High-grade serous ovarian carcinomaNext-generation sequencingTMBTargeted sequencing

More Related Videos

Comparative Lesions Analysis Through a Targeted Sequencing Approach
08:16

Comparative Lesions Analysis Through a Targeted Sequencing Approach

Published on: November 5, 2019

7.2K
Simple and Rapid Method to Obtain High-quality Tumor DNA from Clinical-pathological Specimens Using Touch Imprint Cytology
11:20

Simple and Rapid Method to Obtain High-quality Tumor DNA from Clinical-pathological Specimens Using Touch Imprint Cytology

Published on: March 21, 2018

11.3K

Related Experiment Videos

Last Updated: Jan 8, 2026

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts
10:27

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Published on: July 25, 2020

7.8K
Comparative Lesions Analysis Through a Targeted Sequencing Approach
08:16

Comparative Lesions Analysis Through a Targeted Sequencing Approach

Published on: November 5, 2019

7.2K
Simple and Rapid Method to Obtain High-quality Tumor DNA from Clinical-pathological Specimens Using Touch Imprint Cytology
11:20

Simple and Rapid Method to Obtain High-quality Tumor DNA from Clinical-pathological Specimens Using Touch Imprint Cytology

Published on: March 21, 2018

11.3K

Related Concept Videos

Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

9.3K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
9.3K
Cancers Originate from Somatic Mutations in a Single Cell02:21

Cancers Originate from Somatic Mutations in a Single Cell

14.5K
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
14.5K

Articles linked to this work by shared authors, journal, and citation graph.

Occurrence and preliminary molecular characterization of Sarcocystis spp. in wild Korean roe deer from Jeju Island, Korea.

Parasites, hosts and diseases·2026

Molecular and pathological characterization of a Dirofilaria sp. infection in a little egret (Egretta garzetta).

Parasites, hosts and diseases·2026

Multimodal Large Language Models for Dental Chart Image Interpretation: Cross-Sectional Benchmarking Study With Students and Clinicians.

JMIR medical education·2026

Effects of Bifidobacterium breve B-3 on Glycemic Control and Glucose-Regulatory Responses in db/db Mice.

Journal of microbiology and biotechnology·2026

Foretell Ovary: A Blood-Based Ensemble Algorithm Integrating Tumor-Educated Platelet RNA and Routine Hematology for Non-Invasive Ovarian Cancer Screening.

Cancers·2026

Biocompatibility With Osteogenic Potential of Premixed Bioceramic Cements for Use in Apical Surgery.

Australian endodontic journal : the journal of the Australian Society of Endodontology Inc·2026

Searching for separation between frequency-modulated calls of blue and fin whales.

Scientific reports·2026

Isolation and characterization of plant plasma membrane P-type H+-ATPase dimers.

Scientific reports·2026

Cold-induced vasomotion changes in healthy individuals and patients after median or ulnar nerve repair.

Scientific reports·2026

Integrated expression profiling reveals molecular crosstalk between CFTR, FASN, FRAP (mTOR), and BANK1 in hepatocellular carcinoma.

Scientific reports·2026

Low-cost IoT real-time environmental monitoring and one-hour LSTM forecasting for small-scale agricultural applications.

Scientific reports·2026

Emotion regulation strategy use and daily levels of affective arousal, affective valence and dissociation in a clinical sample.

Scientific reports·2026

Serum small extracellular vesicle-associated snoRNA panel adds diagnostic value to CEA and CYFRA21-1 for non-small cell lung cancer: an exploratory single-center study.

Frontiers in oncology·2026

The value of machine learning models in predicting lung metastasis in papillary thyroid carcinoma.

Frontiers in endocrinology·2026

Integrated bulk-single-cell transcriptomics identifies IL17RB as a candidate prognostic marker in colon cancer.

In silico pharmacology·2026

Development and temporal validation of preoperative and combined preoperative-pathological models for lymph node metastasis in early gastric cancer.

Frontiers in oncology·2026

Other primary malignancies are associated with inferior survival in multiple myeloma: a single-center matched retrospective cohort study.

Frontiers in oncology·2026

Externally validated explainable machine learning for postoperative recurrence prediction in early-stage NSCLC.

Frontiers in oncology·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us